The Wall Street Journal

How a surfie who never finished uni became a biotech billionaire

How a surfie who never finished uni became a biotech billionaire
Bob Duggan is now said to be worth $25.6 billion. (Image: Summit Therapeutics)
The Wall Street Journal
By David WainerThere is a myth that making money in biotechnology stocks requires an advanced degree. But Bob Duggan, an avid surfie who never graduated from university, has proven that notion wrong. Twice.Duggan’s latest investment, Summit Therapeutics, has become one of the industry’s greatest bets in recent years. The stock is up more than 1,000% in the past 12 months thanks to data from a late-stage trial that showed that its drug, Ivonescimab, beat Merck’s blockbuster cancer drug Keytruda in patients with a form of l...

More Health

Food packaging exposing us to microplastics in surprising ways
Health

Food packaging exposing us to microplastics in surprising ways

Highest number of particles that researchers found were in glass bottles.

Radius Care shrugs off aged care ‘crisis’
Markets

Radius Care shrugs off aged care ‘crisis’

Listed retirement providers are reducing their exposure to aged care. 

Gregor Thompson 23 Jun 2025
Mainland Capital delivers $50m raise for Chch hospital expansion
Finance

Mainland Capital delivers $50m raise for Chch hospital expansion

The oversubscribed raise will help fund a new state-of-the-art private hospital facility.

Oliver Lewis 13 Jun 2025
Green Cross Health navigates tough year with $16m profit
Markets

Green Cross Health navigates tough year with $16m profit

The company is navigating a 'challenging healthcare landscape'.

John Anthony 29 May 2025